TP53-mutation status by gene-expression signature (TP53 signature) and prediction of efficacy of neoadjuvant chemotherapy (NAC) and recurrence after surgery in breast cancer.
Shin Takahashi
No relevant relationships to disclose
Takafumi Fukui
No relevant relationships to disclose
Nobuhisa Gondo
No relevant relationships to disclose
Takanori Ishida
No relevant relationships to disclose
Noriaki Ouchi
No relevant relationships to disclose
Tadashi Nomizu
No relevant relationships to disclose
Yoichiro Kakugawa
No relevant relationships to disclose
Chikashi Ishioka
Research Funding - Chugai Pharma; Daiichi Sankyo; Merck Serono